acetylcysteine has been researched along with Thrombotic Microangiopathies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Y; He, X; Hu, S; Pan, T; Qi, J; Tang, Y; Wu, D; Yang, L; Zhang, R | 1 |
| Chen, F; Chen, J; Han, Y; He, X; Hu, X; Liu, Y; Ma, X; Pan, T; Qi, J; Shi, Q; Tang, Y; Wang, H; Wu, D; Wu, X; Xu, X; Yang, J; Yao, Y | 1 |
| Levi, M; Scully, M; Singer, M | 1 |
| Han, S; Han, Y; Miao, W; Pan, T; Qi, J; Ruan, C; Wu, D; Yang, L; You, T; Zhu, L | 1 |
1 review(s) available for acetylcysteine and Thrombotic Microangiopathies
| Article | Year |
|---|---|
The role of ADAMTS-13 in the coagulopathy of sepsis.
Topics: Acetylcysteine; ADAMTS13 Protein; Animals; Blood Coagulation; Humans; Recombinant Proteins; Sepsis; Substrate Specificity; Thrombotic Microangiopathies; von Willebrand Factor | 2018 |
2 trial(s) available for acetylcysteine and Thrombotic Microangiopathies
| Article | Year |
|---|---|
N-Acetylcysteine as Prophylactic Therapy for Transplantation-Associated Thrombotic Microangiopathy: A Randomized, Placebo-Controlled Trial.
Topics: Acetylcysteine; Hematopoietic Stem Cell Transplantation; Humans; Prospective Studies; Retrospective Studies; Thrombotic Microangiopathies | 2022 |
Circulating Heme Oxygenase-1 and Complement Activation in Transplant-Associated Thrombotic Microangiopathy.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Allografts; Child; Complement Activation; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Heme Oxygenase-1; Human Umbilical Vein Endothelial Cells; Humans; Male; Middle Aged; Thrombotic Microangiopathies | 2019 |
1 other study(ies) available for acetylcysteine and Thrombotic Microangiopathies
| Article | Year |
|---|---|
N-Acetyl-L-Cysteine Potentially Inhibits Complement Activation in Transplantation-Associated Thrombotic Microangiopathy.
Topics: Acetylcysteine; Adult; Complement Activation; Female; Hematopoietic Stem Cell Transplantation; Humans; Thrombotic Microangiopathies; Treatment Outcome | 2022 |